Notes to Consolidated Financial Statements
(Unaudited)
1. BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and include all of the information and disclosures required by accounting principles generally accepted in the United States of America for interim reporting, which are less than those required for annual reporting. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (all of which are normal and recurring in nature) necessary to present fairly the financial position of Core Molding Technologies, Inc. and its subsidiaries (“Core Molding Technologies” or the “Company”) at September 30, 2025, and the results of operations and cash flows for the nine months ended September 30, 2025. The “Notes to Consolidated Financial Statements” contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, should be read in conjunction with these consolidated financial statements.
Core Molding Technologies and its subsidiaries operate in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. The Company produces and sells molded products for varied markets, including medium and heavy-duty trucks, power sports, building products, industrial and utilities and other commercial markets. Core Molding Technologies has its headquarters in Columbus, Ohio, and operates six production facilities in the United States, Canada and Mexico.
2. CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Principles of Consolidation: Management believes the following critical accounting policies, among others, affect its more significant judgments and estimates used in the preparation of its consolidated financial statements.
Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions and conditions.
Revenue Recognition: The Company historically has recognized revenue from two streams, product revenue and tooling revenue. Product revenue is earned from the manufacture and sale of sheet molding compounds and thermoset and thermoplastic products. Revenue from product sales is generally recognized when products are shipped, as the Company transfers control to the customer and is entitled to payment upon shipment.
Tooling revenue is earned from manufacturing multiple tools, molds and assembly equipment as part of a tooling program for a customer. Given that the Company is providing a significant service of producing highly interdependent component parts of the tooling program, each tooling program consists of a single performance obligation to provide the customer the capability to produce a single product. Based on the arrangement with the customer, the Company recognizes revenue either at a point in time or over a given period. When the Company does not have an enforceable right to payment, the Company recognizes tooling revenue at a point in time. In such cases, the Company recognizes revenue upon customer acceptance, which is when the customer has legal title to the tools.
Certain tooling programs include an enforceable right to payment. In those cases, the Company recognizes revenue over time based on the extent of progress towards completion of its performance obligation. The Company uses a cost-to-cost measure of progress for such contracts because it best depicts the transfer of value to the customer and also correlates with the amount of consideration to which the entity expects to be titled in exchange for transferring the promised goods or services to the customer. Under the cost-to-cost measure of progress, progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation. Revenues are recorded proportionally as costs are incurred.
Cash and Cash Equivalents: The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash is held primarily in four banks in three separate countries. The Company had $42,397,000 cash on hand at September 30, 2025 and had $41,803,000 cash on hand at December 31, 2024.
Accounts Receivable Allowances: Management maintains allowances for credit losses resulting from the inability of its customers to make required payments. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The Company has determined that $28,000 allowance for credit losses was needed at September 30, 2025 and no allowance for credit losses was needed at December 31, 2024. Management also records estimates for customer returns and deductions, discounts offered to customers, and for price adjustments. Should customer returns and deductions, discounts, and price adjustments fluctuate from the estimated amounts, additional allowances may be required. The Company had an allowance for estimated chargebacks of $224,000 at September 30, 2025 and $227,000 at December 31, 2024. There have been no material changes in the methodology of these calculations.
Inventories: Inventories, which include material, labor and manufacturing overhead, are valued at the lower of cost or net realizable value. The inventories are accounted for using the first-in, first-out (FIFO) method of determining inventory costs. Inventory quantities on-hand are regularly reviewed, and where necessary, provisions for excess and obsolete inventory are recorded based on historical and anticipated usage. The Company has recorded an allowance for slow moving and obsolete inventory of $1,138,000 at September 30, 2025 and $1,392,000 at December 31, 2024.
Contract Assets/Liabilities: Contract assets and liabilities represent the net cumulative customer billings, vendor payments and revenue recognized for tooling programs. For tooling programs where net revenue recognized and vendor payments exceed customer billings, the Company recognizes a contract asset. For tooling programs where net customer billings exceed revenue recognized and vendor payments, the Company recognizes a contract liability. Customer payment terms vary by contract and can range from progress payments based on work performed or one single payment once the contract is completed. The Company has recorded contract assets of $1,410,000 at September 30, 2025, and $758,000 at December 31, 2024. Contract assets are classified as current within prepaid expenses and other current assets on the Consolidated Balance Sheets. For the nine months ended September 30, 2025 and September 30, 2024 the Company recognized no impairments on contract assets. For the nine months ended September 30, 2025, the Company recognized $3,355,000 of revenue from contract liabilities related to open jobs outstanding as of December 31, 2024.
Income Taxes: The Company evaluates the balance of deferred tax assets that will be realized based on the premise that the Company is more-likely-than-not to realize deferred tax benefits through the generation of future taxable income.
Long-Lived Assets: Long-lived assets consist primarily of property, plant and equipment and definite-lived intangibles. The recoverability of long-lived assets is evaluated by an analysis of operating results and consideration of other significant events or changes in the business environment. The Company evaluates whether impairment exists for property, plant and equipment on the basis of undiscounted expected future cash flows from operations before interest. There were no impairment charges of the Company’s long-lived assets for the nine months ended September 30, 2025 and 2024, respectively.
Goodwill: The purchase consideration of acquired businesses has been allocated to the assets and liabilities acquired based on the estimated fair values on the respective acquisition dates. Based on these values, the excess purchase consideration over the fair value of the net assets acquired was allocated to goodwill. The Company accounts for goodwill in accordance with FASB ASC Topic 350, Intangibles - Goodwill and Other. FASB ASC Topic 350 prohibits the amortization of goodwill and requires these assets be reviewed for impairment.
The annual impairment tests of goodwill may be completed through qualitative assessments; however, the Company may elect to bypass the qualitative assessment and proceed directly to a quantitative impairment test for any period. The Company may resume the qualitative assessment in any subsequent period.
Under a qualitative and quantitative approach, the impairment test for goodwill consists of an assessment of whether it is more-likely-than-not that the fair value is less than its carrying amount. As part of the qualitative assessment, the Company considers relevant events and circumstances that affect the fair value or carrying amount of the Company. Such events and circumstances could include changes in economic conditions, industry and market conditions, cost factors, overall financial performance, and capital markets pricing. The Company places more weight on the events and circumstances that most affect the Company's fair value or carrying amount. These factors are all considered by management in reaching its conclusion about whether to perform step one of the impairment test. If the Company elects to bypass the qualitative assessment, or if a qualitative assessment indicates it is more-likely-than-not that the estimated carrying value exceeds its fair value, the Company proceeds to a quantitative approach. There were no impairment charges of the Company's goodwill for the nine months ended September 30, 2025 and 2024, respectively.
Self-Insurance: The Company is self-insured with respect to its facilities in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; and Brownsville, Texas for medical, dental and vision claims and Columbus, Ohio for workers’
compensation claims, all of which are subject to stop-loss insurance thresholds. The Company is also self-insured for dental and vision with respect to its Cobourg, Canada location. The Company has recorded an estimated liability for self-insured medical, dental and vision claims incurred but not reported and worker’s compensation claims incurred but not reported at September 30, 2025 and December 31, 2024 of $901,000 and $1,087,000, respectively. Estimated liabilities for self-insurance are classified as current within accrued other liabilities on the Consolidated Balance Sheets.
Post-Retirement Benefits: Management records an accrual for post-retirement costs associated with the health care plan sponsored by Core Molding Technologies. Should actual results differ from the assumptions used to determine the reserves, additional provisions may be required. In particular, increases in future healthcare costs above the assumptions could have an adverse effect on Core Molding Technologies’ operations. The effect of a change in healthcare costs is described in Note 9, "Post Retirement Benefits", of the Notes to Consolidated Financial Statements contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. Core Molding Technologies had a liability for post-retirement healthcare benefits based on actuarial computed estimates of $3,374,000 at September 30, 2025 and $3,298,000 at December 31, 2024.
3. NET INCOME PER SHARE OF COMMON STOCK
Net income per share of common stock is computed based on the weighted average number of common shares outstanding during the period. Diluted net income per share of common stock is computed similarly but includes the effect of the assumed exercise of dilutive restricted stock under the treasury stock method.
The computation of basic and diluted net income per share of common stock (in thousands, except for per share data) is as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended September 30, | | Nine months ended September 30, | | |
| 2025 | | 2024 | | 2025 | | 2024 | | | | |
| Net income | $ | 1,877 | | | $ | 3,160 | | | $ | 8,112 | | | $ | 13,338 | | | | | |
| | | | | | | | | | | |
| Weighted average shares of common stock outstanding — basic | 8,561 | | | 8,716 | | | 8,583 | | | 8,709 | | | | | |
| Effect of weighted average dilutive securities | 127 | | | 77 | | | 126 | | | 103 | | | | | |
| Weighted average common and potentially issuable shares of common stock outstanding — diluted | 8,688 | | | 8,793 | | | 8,709 | | | 8,812 | | | | | |
| | | | | | | | | | | |
| Basic net income per share of common stock | $ | 0.22 | | | $ | 0.36 | | | $ | 0.95 | | | $ | 1.53 | | | | | |
| Diluted net income per share of common stock | $ | 0.22 | | | $ | 0.36 | | | $ | 0.93 | | | $ | 1.51 | | | | | |
4. MAJOR CUSTOMERS
The Company had five major customers during the nine months ended September 30, 2025, BRP, Inc. ("BRP"), International Motors, LLC (“International”), PACCAR, Inc. ("PACCAR"), Volvo Group North America, LLC ("Volvo") and Yamaha Motor Corporation ("Yamaha"). Major customers are defined as customers whose sales individually consist of more than ten percent of the Company's total sales during any annual or interim reporting period presented. The loss of a significant portion of sales to these customers could have a material adverse effect on the Company.
The following table presents sales revenue for the above-mentioned customers for the three and nine months ended September 30, 2025 and 2024 (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended September 30, | | Nine months ended September 30, | | |
| 2025 | | 2024 | | 2025 | | 2024 | | | | |
| BRP product sales | $ | 8,942 | | | $ | 6,677 | | | $ | 23,514 | | | $ | 23,502 | | | | | |
| BRP tooling sales | 3,648 | | | 153 | | | 4,408 | | | 382 | | | | | |
| Total BRP sales | 12,590 | | | 6,830 | | | 27,922 | | | 23,884 | | | | | |
| | | | | | | | | | | |
| International product sales | 8,968 | | | 17,294 | | | 33,273 | | | 49,932 | | | | | |
| International tooling sales | 5 | | | 430 | | | 14,619 | | | 650 | | | | | |
| Total International sales | 8,973 | | | 17,724 | | | 47,892 | | | 50,582 | | | | | |
| | | | | | | | | | | |
| PACCAR product sales | 5,611 | | | 8,691 | | | 22,904 | | | 29,250 | | | | | |
| PACCAR tooling sales | — | | | 57 | | | 321 | | | 423 | | | | | |
| Total PACCAR sales | 5,611 | | | 8,748 | | | 23,225 | | | 29,673 | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Volvo product sales | 1,164 | | | 10,262 | | | 9,031 | | | 36,487 | | | | | |
| Volvo tooling sales | — | | | — | | | — | | | — | | | | | |
Total Volvo sales | 1,164 | | | 10,262 | | | 9,031 | | | 36,487 | | | | | |
| | | | | | | | | | | |
| Yamaha product sales | 6,895 | | | 8,360 | | | 17,138 | | | 25,694 | | | | | |
| Yamaha tooling sales | — | | | — | | | — | | | — | | | | | |
| Total Yamaha sales | 6,895 | | | 8,360 | | | 17,138 | | | 25,694 | | | | | |
| | | | | | | | | | | |
| Other product sales | 22,598 | | | 19,974 | | | 70,963 | | | 66,180 | | | | | |
| Other tooling sales | 604 | | | 1,094 | | | 2,950 | | | 7,380 | | | | | |
Total other sales | 23,202 | | | 21,068 | | | 73,913 | | | 73,560 | | | | | |
| | | | | | | | | | | |
| Total product sales | 54,178 | | | 71,258 | | | 176,823 | | | 231,045 | | | | | |
| Total tooling sales | 4,257 | | | 1,734 | | | 22,298 | | | 8,835 | | | | | |
Total sales | $ | 58,435 | | | $ | 72,992 | | | $ | 199,121 | | | $ | 239,880 | | | | | |
5. INVENTORY
Inventories, net consisted of the following (in thousands):
| | | | | | | | | | | |
| September 30, 2025 | | December 31, 2024 |
Raw materials | $ | 12,122 | | | $ | 11,656 | |
Work in process | 1,849 | | | 2,368 | |
Finished goods | 5,830 | | | 4,322 | |
Total | $ | 19,801 | | | $ | 18,346 | |
Inventory quantities on-hand are regularly reviewed, and where necessary, provisions for excess and obsolete inventory are recorded based on historical and anticipated usage.
6. LEASES
The Company has operating leases with fixed payment terms for certain buildings and warehouses. The Company's leases have remaining lease terms of less than one year to four years, some of which include options to extend the lease for five years. Operating leases are included in operating lease right-of-use ("ROU") assets, accrued other liabilities and other non-current liabilities in the Consolidated Balance Sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease.
The Company used the applicable incremental borrowing rate at implementation date to measure lease liabilities and ROU assets. The incremental borrowing rate used by the Company was based on baseline rates and adjusted by the credit spreads commensurate with the Company’s secured borrowing rate. At each reporting period when there is a new lease initiated, the Company will utilize its incremental borrowing rate to perform lease classification tests on lease components and to measure ROU assets and lease liabilities.
The components of lease expense were as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended September 30, | | Nine months ended September 30, | | |
| 2025 | | 2024 | | 2025 | | 2024 | | | | |
| Operating lease cost | $ | 517 | | | $ | 524 | | | $ | 1,529 | | | $ | 1,593 | | | | | |
| Short-term lease cost | $ | 336 | | | $ | 499 | | | $ | 1,026 | | | $ | 1,321 | | | | | |
| Total net lease cost | $ | 853 | | | $ | 1,023 | | | $ | 2,555 | | | $ | 2,914 | | | | | |
Other supplemental balance sheet information related to leases was as follows (in thousands):
| | | | | | | | | | | |
| September 30, 2025 | | December 31, 2024 |
| Operating lease right-of-use assets | $ | 4,113 | | | $ | 2,112 | |
| | | |
Current operating lease liabilities(A) | $ | 1,549 | | | $ | 1,178 | |
Noncurrent operating lease liabilities(B) | 2,711 | | | 997 | |
| Total operating lease liabilities | $ | 4,260 | | | $ | 2,175 | |
| | | |
(A)Current operating lease liabilities are included in accrued other liabilities in the Consolidated Balance Sheets.
(B)Noncurrent operating lease liabilities are included in other non-current liabilities in the Consolidated Balance Sheets.
During the nine months ended September 30, 2025, the Company entered into a new lease related to the Cobourg production facility, which resulted in a right-of-use asset of $3,095,000 in exchange for new operating lease liabilities.
7. PROPERTY, PLANT & EQUIPMENT
Property, plant and equipment, net consisted of the following for the periods specified (in thousands):
| | | | | | | | | | | |
| September 30, 2025 | | December 31, 2024 |
| Property, plant and equipment | $ | 229,681 | | | $ | 220,542 | |
| Accumulated depreciation | (148,454) | | | (139,735) | |
| Property, plant and equipment — net | $ | 81,227 | | | $ | 80,807 | |
Property, plant, and equipment are recorded at cost, unless obtained through acquisition, then assets are recorded at estimated fair value at the date of acquisition. Depreciation is provided on a straight-line method over the estimated useful lives of the assets. The carrying amount of long-lived assets is evaluated annually to determine if an adjustment to the depreciation period or to the unamortized balance is warranted. Depreciation expense for the three months ended September 30, 2025 and 2024 was $2,865,000 and $2,979,000, respectively. Depreciation expense for the nine months ended September 30, 2025 and 2024 was $8,722,000 and $8,766,000, respectively. Amounts invested in capital additions in progress were $9,146,000 and $3,437,000 at September 30, 2025 and December 31, 2024, respectively. At September 30, 2025 and December 31, 2024, purchase commitments for capital expenditures in progress were $8,948,000 and $2,802,000, respectively.
8. GOODWILL AND INTANGIBLES
Goodwill activity for the nine months ended September 30, 2025 consisted of the following (in thousands):
| | | | | |
| Balance at December 31, 2024 | $ | 17,376 | |
| Additions | — | |
| Impairment | — | |
| Balance at September 30, 2025 | $ | 17,376 | |
Intangibles, net at September 30, 2025 were comprised of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| Definite-lived Intangible Assets | Amortization Period | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount |
| Trade name | 25 Years | | $ | 250 | | | $ | (106) | | | $ | 144 | |
| Trademarks | 10 Years | | 1,610 | | | (1,241) | | | 369 | |
| Developed technology | 7 Years | | 4,420 | | | (4,420) | | | — | |
| Customer relationships | 10-12 Years | | 9,330 | | | (6,135) | | | 3,195 | |
| Total | | | $ | 15,610 | | | $ | (11,902) | | | $ | 3,708 | |
Intangibles, net at December 31, 2024 were comprised of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| Definite-lived Intangible Assets | Amortization Period | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount |
| Trade name | 25 Years | | $ | 250 | | | $ | (99) | | | $ | 151 | |
| Trademarks | 10 Years | | 1,610 | | | (1,120) | | | 490 | |
| Developed technology | 7 Years | | 4,420 | | | (4,393) | | | 27 | |
| Customer relationships | 10-12 Years | | 9,330 | | | (5,568) | | | 3,762 | |
| Total | | | $ | 15,610 | | | $ | (11,180) | | | $ | 4,430 | |
The aggregate intangible asset amortization expense was $228,000 and $397,000 for the three months ended September 30, 2025 and 2024, respectively. The aggregate intangible amortization expense was $722,000 and $1,190,000 for the nine months ended September 30, 2025 and 2024, respectively.
9. POST-RETIREMENT BENEFITS
The components of expense for the Company’s post-retirement benefit plans are as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended September 30, | | Nine months ended September 30, | | |
| 2025 | | 2024 | | 2025 | | 2024 | | | | |
| Pension expense: | | | | | | | | | | | |
Multi-employer plan | $ | 85 | | | $ | 199 | | | $ | 333 | | | $ | 624 | | | | | |
Defined contribution plan | 425 | | | 459 | | | 1,302 | | | 1,397 | | | | | |
| Total pension expense | 510 | | | 658 | | | 1,635 | | | 2,021 | | | | | |
| Health and life insurance: | | | | | | | | | | | |
Interest cost | 29 | | | 23 | | | 89 | | | 69 | | | | | |
| Amortization of prior service credits | (124) | | | (124) | | | (372) | | | (372) | | | | | |
| Amortization of net gain | (22) | | | (37) | | | (61) | | | (111) | | | | | |
| Net periodic benefit credit | (117) | | | (138) | | | (344) | | | (414) | | | | | |
| Total post-retirement benefits expense | $ | 393 | | | $ | 520 | | | $ | 1,291 | | | $ | 1,607 | | | | | |
The Company made payments of $1,607,000 to pension plans and $98,000 for post-retirement healthcare and life insurance during the nine months ended September 30, 2025. For the remainder of 2025, the Company expects to make approximately $365,000 of pension plan payments, of which $123,000 was accrued at September 30, 2025. The Company also expects to make approximately $36,000 of post-retirement healthcare and life insurance payments for the remainder of 2025, all of which were accrued at September 30, 2025.
10. DEBT
Debt consists of the following (in thousands):
| | | | | | | | | | | |
| September 30, 2025 | | December 31, 2024 |
| | | |
| Huntington term loans payable | 20,312 | | | 21,719 | |
| Leaf Capital term loan payable | — | | | 11 | |
| Total | 20,312 | | 21,730 |
| Less deferred loan costs | (150) | | (210) |
| Less current portion | (1,918) | | (1,814) |
| Long-term debt | $ | 18,244 | | | $ | 19,706 | |
Huntington Credit Agreement
On July 22, 2022, the Company entered into a credit agreement (the “Huntington Credit Agreement”) with The Huntington National Bank (“Huntington”), as the sole lender, administrative agent, lead arranger and book runner, and the lenders from time to time thereto. Pursuant to the terms of the Huntington Credit Agreement, Huntington made available to the Company secured loans (the “Huntington Loans”) in the maximum aggregate principal amount of $75,000,000, comprised of three $25,000,000 commitments: a term loan commitment, a CapEx loan commitment and a revolving loan commitment.
At the option of the Company, the Huntington Loans shall be comprised of Alternative Base Rate (ABR) Loans or Secure Overnight Financing Rate (SOFR) Loans.
ABR Loans bear interest at a per annum rate equal to ABR plus a margin of 280 to 330 basis points determined based on the Company’s leverage ratio. ABR is the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Rate in effect on such day plus 0.50% per annum and (c) Daily Simple SOFR for such day (taking into account any floor set forth in the definition of “Daily Simple SOFR”) plus 1.00% per annum; provided, that if the ABR shall be less than 0.00%, then ABR shall be deemed to be 0.00%.
SOFR Loans bear interest at a per annum rate equal to Daily Simple SOFR plus a margin of 180 to 230 basis points determined based on the Company’s leverage ratio. Daily Simple SOFR means, for any day (a “SOFR Rate Day”), a rate per annum equal to the greater of (a) SOFR for the day (such day, the “SOFR Determination Date”) that is five (5) U.S. Government Securities
Business Days prior to (i) if such SOFR Rate Day is a U.S. Government Securities Business Day, such SOFR Rate Day or (ii) if such SOFR Rate Day is not a U.S. Government Securities Business Day, the U.S. Government Securities Business Day immediately preceding such SOFR Rate Day, in each case, as such SOFR is published by the SOFR Administrator on the SOFR Administrator’s Website, and (b) 0.00%.
The Company’s obligations under the Huntington Credit Agreement are secured by all of the U.S. and Canadian assets of the Company, including all of its equity interests in each of the Company’s U.S. and Canadian subsidiaries and 65% of the Company’s equity interest in its Mexican subsidiaries, and are unconditionally guaranteed by certain subsidiaries of the Company.
The Huntington Credit Agreement contains certain customary representations and warranties, conditions, affirmative and negative covenants and events of default. The Company is in compliance with such covenants as of September 30, 2025.
Voluntary prepayments of amounts outstanding under the Huntington Loans are permitted at any time without premium or penalty.
The Company incurred debt origination fees of $402,000 related to the Huntington Credit Agreement, which is being amortized over the life of the agreement.
Huntington Capex Loan
Pursuant to the terms of the Huntington Credit Agreement, Huntington made available to the Company secured Capex loan (the “Huntington Capex Loan”) in the maximum aggregate principal amount of $25,000,000 which none was outstanding as of September 30, 2025 and December 31, 2024. Proceeds of the Huntington Capex Loan will be used to finance the ongoing capital expenditure needs of the Company.
Any borrowings from the Huntington Capex Loan will be converted to new term loans annually each February, beginning February 2025, and will have monthly principal repayments based on a sixty-month amortization period with all amounts outstanding on the Huntington Capex Loan being fully due on July 22, 2027.
Huntington Revolving Loan
Pursuant to the terms of the Huntington Credit Agreement, Huntington made available to the Company a revolving loan commitment (the “Huntington Revolving Loan”) of $25,000,000. The Company has $25,000,000 of available revolving loans of which none was outstanding as of September 30, 2025 and December 31, 2024.
The Huntington Credit Agreement makes available to the Company a revolving commitment in the maximum amount of $25,000,000 at the Company’s option at any time during the five-year period following the closing. The revolving loan commitment terminates, and all outstanding borrowings thereunder must be repaid on July 22, 2027.
The interest rate for the Huntington Revolving Loan was 5.93% and 6.33% as of September 30, 2025 and December 31, 2024, respectively.
Huntington Term Loan
Pursuant to the terms of the Huntington Credit Agreement, Huntington made available to the Company a Term Loan commitment (the “Huntington Term Loan”) of $25,000,000, all of which was advanced to the Company on July 22, 2022. The Huntington Term Loan is to be repaid in monthly installments beginning August 2022 of $104,000 per month for the first 24 months, $156,000 per month for the next 24 months, $208,000 for the next 12 months and the remaining balance to be paid on July 22, 2027. The interest rate for the Huntington Term Loan was 5.93% and 6.11% as of September 30, 2025 and December 31, 2024, respectively.
Interest Rate Swap Agreement
The Company entered into an interest rate swap agreement that became effective July 22, 2022 and continues through July 2027, which was designed as a cash flow hedge for $25,000,000 of the Huntington Term Loan. Under this agreement, the Company will pay a fixed rate of 2.95% to the swap counterparty in exchange for the Term Loans daily variable SOFR. As a result the interest rate paid on the Huntington Term Loan was 4.75% as of September 30, 2025 and December 31, 2024. The fair value of the interest rate swap was an asset of $138,000 and $491,000 at September 30, 2025 and December 31, 2024, respectively.
11. INCOME TAXES
The Company evaluates the balance of deferred tax assets that will be realized based on the premise that the Company is more-likely-than-not to realize deferred tax benefits through the generation of future taxable income. Management makes assumptions, judgments, and estimates to determine the deferred tax assets and liabilities. The Company evaluates provisions and deferred tax assets quarterly to determine if adjustments to our valuation allowance are required based on the consideration of all available evidence.
At September 30, 2025, the Company had a net deferred tax asset of $1,454,000 and $183,000 related to tax positions in Mexico and Canada, respectively, and deferred tax liabilities of $1,219,000 related to tax positions in the United States. Deferred tax assets are included in "Other non-current assets" on the Consolidated Balance Sheets and deferred tax liabilities are included in "Other non-current liabilities" on the Consolidated Balance Sheets. The Company believes that the deferred tax assets associated with the Canadian, Mexican, and federal United States tax jurisdictions are more-likely-than-not to be realizable based on estimates of future taxable income.
As of September 30, 2025, the Company had a valuation allowance of $1,265,000, against deferred tax assets related to local tax positions in the Unites States, due to cumulative losses over the last three years and uncertainty related to the Company's ability to realize the deferred assets.
Income tax expense for the nine months ended September 30, 2025 is estimated to be $2,840,000, approximately 25.9% of income before income taxes. Income tax expense for the nine months ended September 30, 2024 was estimated to be $3,000,000, approximately 18.4% of income before income taxes.
The Company files income tax returns in the United States, Mexico, Canada and various state and local jurisdictions. The Company is not subject to United States federal income tax examinations for years before 2021. The Company is not subject to state income tax examinations for years before 2021. The Company is not subject to Mexican income tax examinations for years before 2019 and is not subject to Canadian income tax examinations for years before 2020.
12. STOCK BASED COMPENSATION
On May 13, 2021, the Company’s stockholders approved the 2021 Long Term Equity Incentive Plan and approved amendments on May 14, 2024 and May 15, 2025 (as amended, the "2021 Plan"). The 2021 Plan replaced the 2006 Long Term Equity Incentive Plan (the “2006 Plan”) approved in May 2006 and amended in May 2015. The 2021 Plan allows for grants to employees, officers, non-employee directors, consultants, independent contractors and advisors of non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock-based awards (“stock awards”) up to an aggregate of 1,269,823 shares for issuance. At September 30, 2025, 336,841 shares of common stock were available for issuance under the 2021 Plan. Awards can be granted under the 2021 Plan through the earlier of May 13, 2031, or the date the maximum number of available shares under the 2021 Plan have been granted.
Awards under the 2021 Plan vest over one to three years. Shares granted under the 2021 Plans vest immediately upon the date of a participant’s death, disability or change in control.
The Company follows the provisions of FASB ASC 718 requiring that compensation cost relating to share-based payment transactions be recognized in the financial statements. The cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense over the employee's requisite service period (generally the vesting period of the equity award).
During the nine months ended September 30, 2025 employees withheld 40,953 shares of the Company's common stock to satisfy income withholding obligations in connection with the vesting of restricted stock awards, and in the same period in 2024 the Company withheld 72,658 shares.
Restricted Stock
The Company grants shares of its common stock to certain directors, officers, key managers and employees in the form of unvested stock and units (“Restricted Stock”). These awards are measured at the fair value of the Company's common stock on the date of issuance and recognized ratably as compensation expense over the applicable vesting period, which is typically three years. The Company adjusts compensation expense for actual forfeitures, as they occur.
The following summarizes the status of Restricted Stock and changes during the nine months ended September 30, 2025:
| | | | | | | | | | | |
| Number of Shares | | Weighted Average Grant Date Fair Value |
| Unvested balance at December 31, 2024 | 242,910 | | | $ | 15.76 | |
| Granted | 110,472 | | | 12.81 | |
| Vested | (139,495) | | | 14.26 | |
| Forfeited | (16,358) | | | 17.71 | |
| Unvested balance at September 30, 2025 | 197,529 | | | $ | 14.90 | |
At September 30, 2025 and 2024, there was $1,937,000 and $2,907,000, respectively, of total unrecognized compensation expense, related to Restricted Stock grants. The unrecognized compensation expense at September 30, 2025 is expected to be recognized over the weighted-average period of 1.8 years. Total compensation cost related to Restricted Stock grants for the three months ended September 30, 2025 and 2024 was $400,000 and $501,000, respectively. Total compensation cost related to Restricted Stock grants for the nine months ended September 30, 2025 and 2024 was $1,387,000 and $1,914,000, respectively, all of which was recorded to selling, general and administrative expense.
Performance Restricted Stock Awards
The Company grants shares of its common stock to certain officers and key managers in the form of shares of performance based restricted stock ("Performance Restricted Stock Awards"). These awards are measured at the fair value of the Company's common stock on the date of issuance and recognized ratably as compensation expense over the applicable vesting period to the extent that the performance measures have been satisfied as of the last day of the performance period of the award. The total amount payable as of the award's vesting date is determined by the three year average Operational Income and Return on Capital Employed performance measure achievement. The Company adjusts compensation expense for actual forfeitures as they occur, and for estimated performance measure achievement.
The following summarizes the status of Performance Restricted Stock Awards and changes during the nine months ended September 30, 2025:
| | | | | | | | | | | |
| Number of Shares | | Weighted Average Grant Date Fair Value |
| Unvested balance at December 31, 2024 | 38,430 | | | $ | 18.35 | |
| Granted | 68,545 | | | 12.81 | |
| Vested | — | | | — | |
| Forfeited | (7,950) | | | 18.28 | |
| Unvested balance at September 30, 2025 | 99,025 | | | $ | 14.52 | |
At September 30, 2025 and 2024, there was $931,000 and $529,000 of total unrecognized compensation expense related to Performance Restricted Stock Awards, respectively. The unrecognized compensation expense at September 30, 2025 is expected to be recognized over the weighted-average period of 2.1 years. Total compensation cost related to Performance Restricted Stock Awards for the three months ended September 30, 2025 and 2024 was $121,000 and $61,000, respectively. Total compensation cost related to Performance Restricted Stock grants for the nine months ended September 30, 2025 and 2024 was $259,000 and $153,000, respectively, all of which was recorded to selling, general and administrative expense.
Due to award modification as a part of the Executive Transition announced on August 1, 2025, the Company reclassified 28,744 restricted stock awards and 41,200 performance restricted stock awards to liability-classified awards. This
reclassification reduced Paid-in Capital by $45,000 for both the three months and nine months ended September 30, 2025. These awards are measured at the fair value of the Company’s common stock on the modification date and are marked to market at each reporting period. Compensation expense is recognized over the service period of ten months.
13. LONG TERM INCENTIVE COMPENSATION
The Company grants phantom stock ("Phantom Stock Awards") to key employees under the 2021 Plan. These Phantom Stock Awards are measured based on the fair value of the Company's common stock on the vesting date and are marked to market at each reporting period. Compensation expense is recognized over the applicable vesting period, typically three years, and is adjusted for actual forfeitures as they occur.
At September 30, 2025 there was $688,000 of total unrecognized compensation expense related to Phantom Stock Awards. At September 30, 2024 there was $405,000 unrecognized compensation expense related to Phantom Stock Awards. The unrecognized compensation expense at September 30, 2025 is expected to be recognized over the weighted-average period of 2.5 years. Total compensation cost related to Phantom Stock Awards for the three months ended September 30, 2025 was $72,000. Total compensation cost related to Phantom Stock Awards for the nine months ended September 30, 2025 was $136,000, all of which was recorded to selling, general and administrative expense. There was $14,000 compensation cost related to Phantom Stock Awards for the three and nine months ended September 30, 2024.
14. STOCK REPURCHASE PLAN
On March 11, 2024, the Company announced that its Board of Directors approved a stock repurchase program authorizing the Company to repurchase up to $7,500,000 of its outstanding shares of common stock. Repurchases of shares of common stock under the stock repurchase program are made in the open market and in accordance with applicable securities laws. The stock repurchase program does not obligate the Company to acquire any particular amount of common stock, and it may be suspended or terminated at any time at the Company’s discretion. For the three months ended September 30, 2025 no shares were repurchased. For the nine months ended September 30, 2025, 151,584 shares were repurchased under the program, totaling $2,249,000. For the three and nine months ended September 30, 2024, the company repurchased 111,884 shares and 135,873 shares at an average price of $17.60 and $17.40, totaling cash payment of $1,971,000 and $2,364,000, respectively.
15. FAIR VALUE OF FINANCIAL INSTRUMENTS
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in a transaction between market participants as of the measurement date. Fair value is measured using the fair value hierarchy and related valuation methodologies as defined in the authoritative literature. This hierarchical valuation methodology provides a fair value framework that describes the categorization of assets and liabilities in three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.
The three levels are defined as follows:
Level 1 - Quoted prices in active markets for identical assets and liabilities.
Level 2 - Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations, in which all significant inputs are observable in active markets.
Level 3 -Significant unobservable inputs reflecting management's own assumptions about the inputs used in pricing the asset or liability.
The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, debt, interest rate swaps and foreign currency derivatives. Cash and cash equivalents, accounts receivable and accounts payable carrying values as of September 30, 2025 and December 31, 2024 approximate fair value due to the short-term maturities of these financial instruments. As of September 30, 2025 and December 31, 2024, the carrying amounts of the Huntington Term Loan approximated fair value due to the short-term nature of the underlying variable rate SOFR used to determine interest charged on the loans. The Company had Level 2 fair value measurements at September 30, 2025 relating to the Company’s interest rate swaps and foreign currency derivatives.
Derivative and hedging activities
Foreign Currency Derivatives
The Company conducted business in foreign countries and paid certain expenses in foreign currencies; therefore, the Company was exposed to foreign currency exchange risk between the U.S. Dollar and foreign currencies, which could impact the Company’s operating income and cash flows. To mitigate risk associated with foreign currency exchange, the Company entered into forward contracts to exchange a fixed amount of U.S. Dollars for a fixed amount of foreign currency, which will be used to fund future foreign currency cash flows. At inception, all forward contracts are formally documented as cash flow hedges and are measured at fair value each reporting period.
Derivatives are formally assessed both at inception and at least quarterly thereafter, to ensure that derivatives used in hedging transactions are highly effective in offsetting changes in cash flows of the hedged item. If it is determined that a derivative ceases to be a highly effective hedge, or if the anticipated transaction is no longer probable of occurring, hedge accounting is discontinued, and any future mark-to-market adjustments are recognized in earnings. The effective portion of gain or loss is reported in other comprehensive income and the ineffective portion is reported in earnings. The impacts of these contracts were largely offset by gains and losses resulting from the impact of changes in exchange rates on transactions denominated in the foreign currency. As of September 30, 2025, the Company had no ineffective portion related to the cash flow hedges. The notional contract value of foreign currency derivatives was $7,354,000 and $29,668,000 as of September 30, 2025 and December 31, 2024, respectively.
Interest Rate Swap
The Company entered into an interest rate swap contract to fix the interest rate on an initial aggregate amount of $25,000,000 thereby reducing exposure to interest rate changes. The interest rate swap pays a fixed rate of 2.95% to the swap counterparty in exchange for daily SOFR. At inception, all interest rate swaps were formally documented as cash flow hedges and are measured at fair value each reporting period. See Note 10, "Debt", for additional information. The notional contract value of the interest rate swap was $20,312,000 and $21,719,000 as of September 30, 2025 and December 31, 2024, respectively.
Financial statement impacts
The following table detail amounts related to our derivatives designated as hedging instruments (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fair Value of Derivative Instruments September 30, 2025 |
| | Asset Derivatives | | Liability Derivatives |
| | Balance Sheet Location | | Fair Value | | Balance Sheet Location | | Fair Value |
| Foreign exchange contracts | | Prepaid expenses other current assets | | $ | 248 | | | Accrued other liabilities | | $ | 20 | |
| Other non-current assets | | $ | — | | | Other non-current liabilities | | $ | — | |
| | | | | | | | |
| Interest rate swaps | | Prepaid expenses other current assets | | $ | 138 | | | Accrued other liabilities | | $ | — | |
| | Other non-current assets | | $ | — | | | Other non-current liabilities | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fair Value of Derivative Instruments December 31, 2024 |
| | Asset Derivatives | | Liability Derivatives |
| | Balance Sheet Location | | Fair Value | | Balance Sheet Location | | Fair Value |
| Foreign exchange contracts | | Prepaid expenses other current assets | | $ | — | | | Accrued other liabilities | | $ | 2,080 | |
| Other non-current assets | | $ | — | | | Other non-current liabilities | | $ | — | |
| | | | | | | | |
| Interest rate swaps | | Prepaid expenses other current assets | | $ | 351 | | | Accrued other liabilities | | $ | — | |
| | Other non-current assets | | $ | 140 | | | Other non-current liabilities | | $ | — | |
The following tables summarize the amount of unrealized and realized gain (loss) recognized in Accumulated Other Comprehensive Income ("AOCI") for the three months ended September 30, 2025 and 2024 (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Derivatives in subtopic 815-20 Cash Flow Hedging Relationship: | | Amount of Unrealized Gain (Loss) Recognized in Accumulated Other Comprehensive Income on Derivative | | Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income(A) | | Amount of Realized Gain (Loss) Reclassified from Accumulated Other Comprehensive Income |
| | 2025 | | 2024 | | | | 2025 | | 2024 |
| Foreign exchange contracts | | $ | (91) | | | $ | (1,756) | | | Cost of goods sold | | $ | 182 | | | $ | (551) | |
| | | | | | Selling, general and administrative expense | | $ | 27 | | | $ | (164) | |
| Interest rate swaps | | $ | (72) | | | $ | (427) | | | Interest expense | | $ | (22) | | | $ | 132 | |
The following tables summarize the amount of unrealized and realized gain (loss) recognized in AOCI for the nine months ended September 30, 2025 and 2024 (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Derivatives in subtopic 815-20 Cash Flow Hedging Relationship: | | Amount of Unrealized Gain (Loss) Recognized in Accumulated Other Comprehensive Income on Derivative | | Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income(A) | | Amount of Realized Gain (Loss) Reclassified from Accumulated Other Comprehensive Income |
| | 2025 | | 2024 | | | | 2025 | | 2024 |
| Foreign exchange contracts | | $ | 2,147 | | | $ | (2,972) | | | Cost of goods sold | | $ | (140) | | | $ | (246) | |
| | | | | | Selling, general and administrative expense | | $ | (21) | | | $ | (54) | |
| Interest rate swaps | | $ | (135) | | | $ | 121 | | | Interest expense | | $ | 218 | | | $ | 406 | |
(A) The foreign currency derivative activity reclassified from Accumulated Other Comprehensive Income is allocated to cost of goods sold and selling, general and administrative expense based on the percentage of foreign currency spend.
16. ACCUMULATED OTHER COMPREHENSIVE INCOME
The following table presents changes in Accumulated Other Comprehensive Income, net of tax, for the nine months ended September 30, 2025 and 2024 (in thousands):
| | | | | | | | | | | |
| 2024: | Derivative Hedging Activities | Post Retirement Benefit Plan Items(A) | Accumulated Other Comprehensive Income (Loss) |
| 2024: | | | |
| Balance at December 31, 2023 | $ | 901 | | $ | 4,400 | | $ | 5,301 | |
| | | |
| Other comprehensive income before reclassifications | (2,851) | | — | | (2,851) | |
| Amounts reclassified from accumulated other comprehensive income | (106) | | (483) | | (589) | |
| Income tax benefit | 621 | | 101 | | 722 | |
| Balance at September 30, 2024 | $ | (1,435) | | $ | 4,018 | | $ | 2,583 | |
| | | |
| 2025: | | | |
| Balance at December 31, 2024 | $ | (1,254) | | $ | 3,546 | | $ | 2,292 | |
| Other comprehensive income before reclassifications | 2,012 | | — | | 2,012 | |
| Amounts reclassified from accumulated other comprehensive income | (57) | | (433) | | (490) | |
| Income tax benefit (expense) | (411) | | 91 | | (320) | |
| Balance at September 30, 2025 | $ | 290 | | $ | 3,204 | | $ | 3,494 | |
(A)The effect of post-retirement benefit items reclassified from Accumulated Other Comprehensive Income is included in other income and expense on the Consolidated Statements of Operations. These Accumulated Other Comprehensive Income components are included in the computation of net periodic benefit cost (see Note 9, "Post-Retirement Benefits" for additional details). The tax effect of post-retirement benefit items reclassified from Accumulated Other Comprehensive Income is included in income tax expense on the Consolidated Statements of Operations.
17. SEGMENT REPORTING
Segment information is prepared on the same basis that our Chief Executive Officer ("CEO"), who serves as our Chief Operating Decision Maker ("CODM"), manages our business, evaluates financial results, and makes key operating decisions. The North America reportable operating segment comprises all manufacturing operations located in the United States, Canada, and Mexico, which we have aggregated into a single reportable operating segment, North America, in consideration of the aggregation criteria set forth in ASC 280. These operations share similar economic characteristics, production processes, and customer bases. The North America reportable segment generates its revenue primarily from the manufacturing and sale of sheet molding compound and molded structural plastic products to customers in the heavy truck, power sports, building products and industrial markets. Our CODM uses income from operations to evaluate performance and make key operating decisions, such as allocating resources and assessing growth opportunities within the North America segment. The CODM is not provided asset information by reportable segment, as asset information is reviewed on a consolidated basis.
The following tables present selected financial information with respect to our single reporting segment for the three and nine months ended September 30, 2025 and 2024 (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended September 30, | | Nine months ended September 30, |
| 2025 | | 2024 | | 2025 | | 2024 |
| North America Segment: | | | | | | | |
| Product sales | $ | 54,178 | | | $ | 71,258 | | | $ | 176,823 | | | $ | 231,045 | |
| Tooling sales | 4,257 | | | 1,734 | | | 22,298 | | | 8,835 | |
| North America Segment Total Revenue | 58,435 | | | 72,992 | | | 199,121 | | | 239,880 | |
| | | | | | | |
| Less: | | | | | | | |
Variable Cost of Goods Sold | 41,850 | | | 53,215 | | | 142,357 | | | 173,686 | |
| Fixed Cost of Goods Sold | 6,440 | | | 7,432 | | | 20,522 | | | 22,819 | |
| Selling, Goods and Administration | 7,572 | | | 8,740 | | | 25,616 | | | 27,550 | |
| North America Segment Operating Income | 2,573 | | | 3,605 | | | 10,626 | | | 15,825 | |
| | | | | | | |
| Less: | | | | | | | |
| Net interest (income) expense | 34 | | | (144) | | | 18 | | | (99) | |
| Net periodic post retirement benefit | (117) | | | (138) | | | (344) | | | (414) | |
| Income taxes | 779 | | | 727 | | | 2,840 | | | 3,000 | |
| North America Net Income | 1,877 | | | 3,160 | | | 8,112 | | | 13,338 | |
| | | | | | | |